Nonprofit · EIN 95-4002032
ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Tax-exempt · SANTA CLARITA, CA 91355
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| March 31, 2026 | 990 | $257,887,615 | $72,682,511 | $185,205,104 | $567,896,814 | $12,714,596 | $555,182,218 |
| March 31, 2025 | 990 | $18,144,382 | $41,776,524 | -$23,632,142 | $353,361,768 | $6,385,007 | $346,976,761 |
| March 31, 2024 | 990 | $44,147,259 | $31,844,936 | $12,302,323 | $372,537,856 | $6,669,955 | $365,867,901 |
Financial details: 990 for the year ended March 31, 2026
Revenue
- Contributions, gifts and grants
- $46,500
- Program service revenue
- $10,105,218
- Investment income
- $21,531,091
- Royalties
- $1,204,806
- Net gain from sales of assets
- $11,292,051
- Other revenue
- $226,204,806
Expenses
- Grants and similar amounts paid
- $10,000
- Compensation of officers, directors and key employees
- $6,705,576
- Other salaries and wages
- $34,070,288
- Salaries, compensation and benefits (total)
- $44,932,488
- Professional fundraising fees
- $0
- Legal fees
- $11,511,097
- Accounting fees
- $188,648
- Occupancy
- $1,825,551
- Travel
- $587,919
- Depreciation
- $1,504,344
- Program services (functional)
- $66,209,189
- Management and general (functional)
- $6,473,322
Balance sheet and other
- Total assets, start of year
- $353,361,768
- Total assets, end of year
- $567,896,814
- Total liabilities, end of year
- $12,714,596
- Net assets, end of year
- $555,182,218
- Land, buildings and equipment
- $5,331,576
- Publicly traded securities
- $229,458,245
- Net assets without donor restrictions
- $555,182,218
- Gross unrelated business income
- $125
- Gross receipts
- $298,778,593
- Employees
- 147
- Volunteers
- 4
- Year formed
- 1985
- State of legal domicile
- CA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended March 31, 2026, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| ROBERT GREENBERG | CEO/PRESIDENT/CHAIR OF THE BOARD Trustee or director, Officer | 40 | $1,702,823 | $128,489 |
| FARAH BOROOMAND | CHIEF FINANCIAL OFFICER/TREASURER Officer | 40 | $674,156 | $65,659 |
| COREY DISHMON | CHIEF BUSINESS AND LEGAL OFFICER Officer | 40 | $591,154 | $39,697 |
| NEIL TALBOT | VP, RESEARCH AND TECHNOLOGY Highest-paid employee | 40 | $475,370 | $43,404 |
| JOHN RIVERA | VICE PRESIDENT, PRODUCT DEVELOPMENT Key employee | 41 | $371,763 | $50,464 |
| BRIAN SHELTON | SENIOR DIR, SOFTWARE ENGINEERING Highest-paid employee | 40 | $387,389 | $25,252 |
| CEDRIC NAVARRO | VP, QUALITY ASSURANCE, REG. AFFAIRS, OPERATIONS Key employee | 40 | $335,094 | $50,020 |
| JOSEPH CALDERON | SENIOR DIR, MECHANICAL ENGINEER Highest-paid employee | 43 | $327,174 | $51,008 |
| SHAWN LEWIS | VICE PRESIDENT, HUMAN RESOURCES Highest-paid employee | 40 | $353,262 | $12,647 |
| BRIAN MECH | VICE PRESIDENT, STRATEGY Highest-paid employee | 40 | $330,942 | $11,366 |
| PHILIP LEE | SECRETARY/ ASSISTANT GENERAL COUNSEL Officer | 40 | $228,422 | $30,806 |
| DAVID GILL | BOARD MEMBER Trustee or director | 1.5 | $0 | $0 |
| HEATHER PAGE | BOARD MEMBER Trustee or director | 1.25 | $0 | $0 |
| KEN WEATHERWAX | BOARD MEMBER Trustee or director | 1.25 | $0 | $0 |
| RICHARD WAUGH | BOARD MEMBER Trustee or director | 1.5 | $0 | $0 |
990 for the year ended March 31, 2025: 15 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| ROBERT GREENBERG | CEO/PRESIDENT/CHAIR OF THE BOARD Trustee or director, Officer | 44 | $1,176,449 | $145,692 |
| FARAH BOROOMAND | CHIEF FINANCIAL OFFICER/TREASURER Officer | 44 | $510,007 | $64,791 |
| COREY DISHMON | CHIEF BUSINESS AND LEGAL OFFICER Officer | 40 | $404,186 | $23,740 |
| JOHN RIVERA | VICE PRESIDENT, PRODUCT DEVELOPMENT Key employee | 41 | $357,505 | $32,174 |
| NEIL TALBOT | VP, RESEARCH AND TECHNOLOGY Highest-paid employee | 42 | $321,393 | $39,729 |
| SHAWN LEWIS | VICE PRESIDENT, HUMAN RESOURCES Highest-paid employee | 40 | $318,397 | $39,172 |
| CEDRIC NAVARRO | V.P. QUALITY ASSURANCE, REG. AFFAIRS, INTERIM Key employee | 40 | $283,665 | $53,331 |
| CARL BUICE | SENIOR DIRECTOR, PROJECT MANAGEMENT Highest-paid employee | 40 | $280,991 | $43,754 |
| BRIAN MECH | VP, STRATEGY Highest-paid employee | 40 | $306,807 | $9,977 |
| VALMA KLEIN | VP, CLINICAL AFFAIRS Highest-paid employee | 41 | $274,441 | $32,066 |
| PHILIP LEE | SECRETARY/ASSISTANT GENERAL COUNSEL Officer | 40 | $216,632 | $39,503 |
| KEN WEATHERWAX | BOARD MEMBER Trustee or director | 1.25 | $0 | $0 |
| RICHARD WAUGH | BOARD MEMBER Trustee or director | 1.5 | $0 | $0 |
| DAVID GILL | BOARD MEMBER Trustee or director | 1.5 | $0 | $0 |
| HEATHER PAGE | BOARD MEMBER Trustee or director | 1.25 | $0 | $0 |
990 for the year ended March 31, 2024: 24 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| ROBERT GREENBERG | CEO, EXECUTIVE CHAIRMAN OF THE BOARD Trustee or director, Officer | 44 | $1,126,805 | $83,221 |
| FARAH BOROOMAND | CHIEF FINANCIAL OFFICER Officer | 44 | $485,271 | $78,169 |
| COREY DISHMON | CHIEF BUSINESS AND LEGAL OFFICER Officer | 40 | $373,573 | $21,387 |
| NEIL TALBOT | VP, RESEARCH AND TECHNOLOGY Officer | 40 | $306,031 | $25,285 |
| BRIAN MECH | VP, STRATEGY Officer | 40 | $293,384 | $10,804 |
| BRIAN SHELTON | DIRECTOR, SOFTWARE AND SYSTEMS DEV Key employee | 40 | $266,396 | $29,899 |
| VALMA KLEIN | VP, CLINICAL AFFAIRS Officer | 41.5 | $258,851 | $37,397 |
| JOSEPH CALDERON | DIRECTOR, MECHANICAL ENGINEERING Key employee | 45.5 | $242,808 | $43,638 |
| CEDRIC NAVARRO | V.P. QUALITY ASSURANCE, REG. AFFAIRS, INTERIM Officer | 40 | $223,160 | $49,480 |
| CHRISTOPHER FLECK | MANUFACTURING ENGINEERING DIRECTOR Highest-paid employee | 40 | $240,335 | $28,224 |
| SHAWN LEWIS | VICE PRESIDENT, HUMAN RESOURCES Officer | 40 | $229,291 | $27,894 |
| JOHN RIVERA | VICE PRESIDENT, PRODUCT DEVELOPMENT Officer | 40 | $218,311 | $32,348 |
| PHILIP LEE | ASSISTANT GENERAL COUNSEL Officer | 40 | $207,894 | $42,024 |
| RANKIRI TISSA KARUNASIRI | ELECTRICAL ENGINEERING FELLOW Highest-paid employee | 40 | $208,870 | $40,961 |
| ANTHONY NG | DIRECTOR, ELECTRICAL ENGINEERING Key employee | 40 | $202,889 | $38,485 |
| HITESH HOTLANI | SOFTWARE ENGINEERING MANAGER Highest-paid employee | 40 | $207,074 | $27,622 |
| WILLIAM BRANDT | SR. PRINCIPAL MECHANICAL ENGINEER Highest-paid employee | 46 | $205,604 | $26,544 |
| SAM BOWMAN THRU 122823 | PRINCIPAL ENGINEER ELECTRICAL Highest-paid employee | 40 | $214,087 | $13,533 |
| CHARLES NELSON | FORMER CHIEF OPERATING OFFICER Former | 0 | $149,194 | $11,204 |
| KEN WEATHERWAX | BOARD MEMBER Trustee or director | 1.25 | $0 | $0 |
| RICHARD WAUGH | BOARD MEMBER Trustee or director | 1.5 | $0 | $0 |
| DAVID GILL | BOARD MEMBER Trustee or director | 1.5 | $0 | $0 |
| HEATHER PAGE | BOARD MEMBER Trustee or director | 1.25 | $0 | $0 |
| DAVID SCOTT | BOARD MEMBER (THRU 11/23) Trustee or director | 1.25 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 25134 RYE CANYON LOOP, SANTA CLARITA, CA 91355-5045
- Principal officer (990 for 2025)
- ROBERT GREENBERG, 25134 RYE CANYON LOOP, SANTA CLARITA, CA 91355
- Signed the 990
- ROBERT GREENBERG, CEO
- Phone
- (661) 702-6700
- Return prepared by
- BAKER TILLY ADVISORY GROUP LP
Mission
THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH (AMF) DBA HUMANNITY MEDTEC (HMT) IS A MEDICAL RESEARCH ORGANIZATION DEDICATED TO DEVELOPING AND COMMERCIALIZING INNOVATIVE SOLUTIONS FOR SIGNIFICANT UNMET MEDICAL CONDITIONS.
Program accomplishments
- NEW PROJECT DEVELOPMENTTHIS PROGRAM COVERS (A) THE MONITORING AND EVALUATION OF SEVERAL EARLY STAGE ADVANCED RESEARCH AND DEVELOPMENT EFFORTS UNDERWAY THAT ARE DIRECTED AT DEVELOPING - INNOVATIVE TECHNOLOGIES, PROJECT IDEAS AND CONCEPTS BEFORE THEY PROGRESS TO THE STATUS OF FULL-FLEDGED DEVELOPMENT PROGRAMS, AND (B) ONGOING EFFORTS RELATED TO THE ADVANCEMENT OF COMMERCIAL DEVELOPMENT AND PROTECTION OF INTELLECTUAL PROPERTY OF THESE PROJECTS ACROSS THE DEVELOPMENT LIFECYCLE. THE TEAM COMPRISES THE FULL RANGE OF EXPERTISE AVAILABLE AT AMF/HMT, INCLUDING EXECUTIVE MANAGEMENT, RESEARCH SCIENTISTS AND ENGINEERS, LEGAL AND INTELLECTUAL PROPERTY EXPERTS, BUSINESS DEVELOPMENT STRATEGISTS AND ANALYSTS.EXPENSES MAY INCLUDE ONGOING PARTICIPATION IN THE DEVELOPMENT EFFORT, INCLUDING RESEARCH AND DEVELOPMENT SUPPORT, COLLABORATION MANAGEMENT, CONFERENCE AND PROFESSIONAL SOCIETY MEETING ATTENDANCE, SERVICE IN MANAGEMENT OR ON THE BOARD OF DIRECTORS OF SPINOUT ENTITIES, PATENT PROSECUTION AND THE PROSECUTION OF INFRINGEMENT ACTIONS TO PROTECT THE VALUE OF THE INTELLECTUAL PROPERTY WE CREATE. IN ADDITION TO PAYROLL EXPENSES AND DIRECT EXPENSES PAID TO OUTSIDE VENDORS FOR GOODS AND SERVICES RELATED TO PROJECTS, EXPENSES IN THIS PROGRAM MAY INCLUDE TRAVEL EXPENSES, PATENT PROSECUTION EXPENSES AND FEES, LEGAL FEES FOR EXPENSES TO CREATE, PRESERVE AND PROTECT INTELLECTUAL PROPERTY FROM INFRINGEMENT AND REMEDY PAST INFRINGEMENT, AND INCENTIVE AND OTHER COMPENSATION PAYMENTS TO EMPLOYEES AND OTHERS RELATED TO THESE PROGRAMS AND ACTIONS. IN SOME CASES, CERTAIN OF THESE EXPENDITURES MIGHT BE INCURRED LONG AFTER THE PROGRAMS HAVE BEEN LAUNCHED INTO SPINOUT COMPANIES OR LICENSED TO THIRD PARTIES.REVENUES ASSOCIATED WITH THESE PROJECTS (SOME OF WHICH MAY ACCRUE LONG AFTER THE PROJECT AND ANY RELATED PROGRAM HAVE BEEN OUTLICENSED OR LAUNCHED INTO A SPINOUT COMPANY) MAY INCLUDE: RECOVERIES OF JUDGMENTS OR SETTLEMENTS FROM PATENT INFRINGEMENT AND LICENSING MATTERS, ROYALTIES ON LICENSED PRODUCT SALES, MILESTONE PAYMENTS, ONGOING CONTRACT R&D SERVICES PROVIDED TO PARTNERS, LICENSEES AND SPINOUT COMPANIES, INTEREST, AND PROCEEDS FROM LIQUIDITY EVENTS (E.G., INITIAL PUBLIC OFFERINGS, ACQUISITIONS) INVOLVING RETAINED EQUITY INTERESTS IN PROJECTS THAT HAVE BEEN SPUN OUT AS STARTUP COMPANIES.STATUS:DESIGN AND DEVELOPMENT ACTIVITIES ARE UNDERWAY FOR A NEW BIOELECTRONIC PROGRAM BASED ON EXISTING BUSINESS CASE ANALYSES. THESE ACTIVITIES INCLUDE GENERATION OF INITIAL SYSTEM REQUIREMENTS, ASSEMBLY OF A TEAM OF KEY OPINION LEADERS WITH DOMAIN EXPERTISE, AND THE INITIATION OF SOME FUNDAMENTAL APPLIED RESEARCH IN THE AREA OF NOVEL STIMULATION TECHNIQUES, INCLUDING COMPLETION OF PRE-CLINICAL TESTING. ADDITIONALLY, THE BUSINESS DEVELOPMENT TEAM, ALONG WITH EXECUTIVE MANAGEMENT AND OTHER STAFF, PERFORMED PRELIMINARY DUE DILIGENCE ON A NUMBER OF PROJECTS.Expenses $36,717,119 · revenue $226,308,037
- NEUROMODULATION SYSTEMADVANCED IMPLANTABLE NEUROMODULATION SYSTEM DEVELOPMENT:THIS PROGRAM COVERS (A) THE MONITORING AND EVALUATION OF SEVERAL EARLY-STAGE ADVANCED RESEARCH AND DEVELOPMENT EFFORTS UNDERWAY THAT ARE DIRECTED AT DEVELOPING INNOVATIVE TECHNOLOGIES, PROJECT IDEAS AND CONCEPTS BEFORE THEY PROGRESS TO THE STATUS OF FULL-FLEDGED DEVELOPMENT PROGRAMS, AND (B) ONGOING EFFORTS RELATED TO THE ADVANCEMENT OF COMMERCIAL READINESS AND PROTECTION OF RELATED INTELLECTUAL PROPERTY ACROSS THE DEVELOPMENT LIFECYCLE. THE TEAM COMPRISES THE FULL RANGE OF EXPERTISE AVAILABLE AT AMF/HMT, INCLUDING EXECUTIVE MANAGEMENT, RESEARCH SCIENTISTS AND ENGINEERS, LEGAL AND INTELLECTUAL PROPERTY EXPERTS, BUSINESS DEVELOPMENT STRATEGISTS AND ANALYSTS.STATUS RESEARCH AND DEVELOPMENT ACTIVITIES ARE UNDERWAY TO ENHANCE THE CAPABILITIES OF A NEUROMODULATION SYSTEM, COMPRISED OF ADVANCED TECHNOLOGIES AND SYSTEM SOLUTIONS IN SUPPORT OF NEW BUSINESS DEVELOPMENT STRATEGIES.Expenses $16,985,902 · grants $10,000
- IMPLANTABLE NEUROMODULATION PROJECT #1 TO TREAT CHRONIC DISEASE -THE AIM OF THE AMF/HMT PROGRAM IS TO DEVELOP A NEUROSTIMULATION SYSTEM THAT WILL IMPROVE MEDICAL OUTCOMES AT A LOWER COST AND/OR HIGHER PATIENT SATISFACTION THAN CURRENTLY AVAILABLE TREATMENT OPTIONS. SUCH A SYSTEM WILL CONSIST OF A FULLY IMPLANTABLE NEURAL STIMULATOR FOR SEAMLESS OPERATION AND REQUIRING MINIMAL INTERACTION FROM A PATIENT, WITH THE GOAL OF OFFERING A HIGHER LEVEL OF PATIENT SATISFACTION, ADOPTION, AND COMPLIANCE.STATUS:FINAL DESIGN VERIFICATION TESTING ACTIVITIES OF THE IMPLANTABLE DEVICE AND EXTERNALS ARE COMPLETED. A FIRST-IN-HUMAN STUDY TO ASSESS THE SYSTEM DESIGN AND THERAPY IS ONGOING.Expenses $10,033,758
- IMPLANTABLE NEUROMODULATION PROJECT #2: A-$279,169.06 & B-$2,187,790.66TO TREAT A RANGE OF NEUROLOGICAL CONDITIONS. THE SYSTEM WILL CONSIST OF AN IMPLANTABLE NEURAL STIMULATOR AND EXTERNALS DESIGNED TO MAXIMIZE THERAPY OUTCOMES AND PATIENT SATISFACTION WHILE MINIMIZING SYSTEM COSTS.STATUS:PLANNING, DESIGN, AND DEVELOPMENT OF THE FIRST IN-HUMAN IMPLANT AND EXTERNALS IS UNDERWAY; FEASIBILITY PLANNING AND INITIATIVES INCLUDE PRE-CLINICAL STUDIES AND COMPUTATIONAL MODELING OF TARGETED NEURAL STRUCTURES.Expenses $2,466,959
- IMPLANTABLE DRUG PUMP (IDP)THE IDP IS A SOPHISTICATED, HIGHLY PROGRAMMABLE DRUG INFUSION DEVICE THAT IS IMPLANTED IN THE BODY AND REFILLED VIA A HYPODERMIC NEEDLE THROUGH THE SKIN. INFUSION RATES AND SCHEDULES MAY BE PROGRAMMED, AND VIA VARIOUS FORMS OF CATHETERS, DRUGS CAN BE DELIVERED INTRATHECALLY TO THE SPINAL COLUMN, INTO THE ABDOMEN, INTO THE BRAIN, OR INTRAVENOUSLY. STATUS: AMF/HMT HAS SOLD THE IDP TECHNOLOGY TO A STRATEGIC PARTNER THAT IS AN INTERNATIONAL MEDICAL DEVICE COMPANY. AMF/HMT CONTINUES TO SUPPORT THE STRATEGIC PARTNER AS IT CONDUCTS CLINICAL TRIALS AND READIES IT FOR COMMERCIALIZATION FOR THE BENEFIT OF PATIENTS.Expenses $5,451 · revenue $10,001,987
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in March, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | March 31, 2026 | August 17, 2026 | 990 on file |
| 2024 | March 31, 2025 | August 15, 2025 | 990 on file |
| 2023 | March 31, 2024 | August 15, 2024 | 990 on file |
IRS record
- EIN
- 95-4002032
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Hospital or medical research organization
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1986
- Accounting year ends
- March
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Science and technology (U200)
- Assets (IRS master file)
- $567,896,814
- Income (IRS master file)
- $298,778,593
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | March 2026 | – | – | – | IRS |
| 990-T | March 2026 | – | – | – | IRS |
| 990 | March 2025 | – | – | – | IRS |
| 990-T | March 2025 | – | – | – | IRS |
| 990 | March 2024 | $44,147,259 | $31,844,936 | $372,537,856 | IRS |
| 990-T | March 2024 | – | – | – | IRS |
| 990 | March 2023 | $31,054,042 | $22,822,234 | $344,680,217 | IRS |
| 990-T | March 2023 | – | – | – | IRS |
| 990 | March 2022 | – | – | – | IRS |
| 990-T | March 2022 | – | – | – | IRS |
| 990 | March 2021 | – | – | – | IRS |
| 990-T | March 2021 | – | – | – | IRS |
| 990 | March 2020 | – | – | – | IRS |
990-N: the IRS publishes only the latest e-Postcard per organization; earlier years appear here as 990.tax collects the monthly files. 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS.
Questions about ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH
- What is the EIN of ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH?
- The employer identification number (EIN) of ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH is 95-4002032.
- Is ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1986.
- Are donations to ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH due?
- The return for tax year 2026 (the year ending March 31, 2027) is due August 16, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended March 2026.
- Who is the principal officer of ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH?
- The 990 for the year ended March 31, 2026 names ROBERT GREENBERG.
- Who are the officers and directors of ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH?
- The 990 for the year ended March 31, 2026 lists 15 people; 11 received compensation from the organization, the highest $1,702,823 (ROBERT GREENBERG, CEO/PRESIDENT/CHAIR OF THE BOARD).
- How much revenue does ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH have?
- On its 990 for the year ended March 31, 2026 it reported revenue of $257,887,615, expenses of $72,682,511 and total assets of $567,896,814 at year end.
Other nonprofits in SANTA CLARITA
- GUPTA INSTITUTE OF UNITY SCIENCE EIN 41-2332903 · last filed 990-N for 2025
- SOCIETY OF SATELLITE PROFESSIONALS INTERNATIONAL SOUTHERN CA CHAPTER EIN 95-4687907 · last filed 990-N for 2024
- TECHNOVATE FOUNDATION EIN 93-4850089 · last filed 990-PF for 2025
- THE MASTERS UNIVERSITY AND SEMINARY EIN 95-6001907 · last filed 990 for 2023
- CHILD & FAMILY CENTER EIN 95-3941342 · last filed 990 for 2025
- SANTA CLARITA VALLEY COMMITTEE ON AGING INC EIN 95-3081997 · last filed 990 for 2025
- LOS ANGELES RESIDENTIAL COMMUNITY FOUNDATION EIN 95-2134243 · last filed 990 for 2025
- ZOE INTERNATIONAL EIN 14-1862549 · last filed 990 for 2025
All nonprofits in SANTA CLARITA · California · Science and technology